Medtronic plc MDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump.

Medtronic (MDT +0.3%) has filed an application with the FDA seeking approval for non-adjunctive labeling for its Guardian Sensor 3, part of the MiniMed 670G closed-loop insulin pump system.

The pump then automatically adjusts the amount of insulin given every 5 minutes. The MiniMed TM 670G gained approval in 2016 for people ages 14 and older and in 2018 for children ages 7 to 13 ...

The MiniMed 670G is the first device that allows a glucose sensor to communicate with an insulin pump and automatically regulate the insulin flow. The device is approved for those aged 14 and older.

The Guardian 3 sensor is “not intended to be used directly for making therapy adjustments.” That is a direct quote from the Medtronic website. While the 670G system operates based on the ...

Medtronic shared data showing that the 670G has grown sensor attachment, with 65% of users using a sensor vs. 35% prior. The increased adoption translates to an annual revenue uplift per customer ...

Sales of the company’s MiniMed 670G device, which is the med-tech giant's latest “artificial pancreas” system, partly drove the diabetes division's strong performance.

The Guardian Connect uses the Guardian 3 sensor, which is the latest sensor from Medtronic and powers its hybrid closed-loop insulin pump, the 670G.

To reduce the risk of blood sugar highs and lows, Medtronic developed the 670G, a system that uses a blood glucose sensor, an insulin pump, and an infusion patch to automatically keep a type 1 ...

Summary Medtronic's Diabetes Group is the smallest, but fastest growing segment in the company's portfolio. Investors are excited about its prospects due to the 670G insulin pump.

Diabetes: The Medtronic MiniMed 670G is the first hybrid closed-loop system — also known as an “artificial pancreas” for its ability to predict and prevent an increase or a decrease in ...

The system comprises Medtronic’s MiniMed 670G insulin pump that is strapped to the body, an infusion patch that delivers insulin via catheter from the pump and a sensor that measures glucose ...